RSV prevention promotion for children.

What is RSV? Why is it dangerous for your child ? RSV (Respiratory Syncytial Virus) is a virus that causes respiratory infections in young children, which can worsen symptoms rapidly.

Statistics and risks parents should know :

• Most common in young children : 75% of infections occur in children under 5 years old.
• Risk of hospitalization: More than 50% of infected children require prolonged hospitalization.
• Age groups requiring special attention: Especially children under 24 months of age are at high risk for serious complications such as bronchiolitis, pneumonia, otitis media, and middle ear infections.
• Long-term effects: RSV infection in the early years of life may increase the risk of developing asthma in the future.

Why choose RSV Enflonsia (Clesrovimab) immunotherapy?

Just one injection: Provides protection for approximately 6 months.

Seasonal coverage: Covers the peak RSV season in Thailand (June - October).

A worry-free option: Suitable for young children to help reduce the severity of respiratory illnesses.

Maximum protection effectiveness (based on data from the Clever Study):

Reduces the chance of severe pneumonia requiring medical attention by up to 88%.

Reduces the rate of hospitalization by up to 84.2%.

Reduces the severity of the disease to the point of requiring mechanical ventilation in the Intensive Care Unit (ICU) by up to 91.7%.

Program Details